BIVALIRUDIN VERSUS HEPARIN MONOTHERAPY IN PERCUTANEOUS CORONARY INTERVENTION PATIENTS: AN ANALYSIS OF ACUTE ADVERSE OUTCOMES AND COST

被引：0
|
作者：
Ephrem, Georges [1 ]
Guenoun, Jonathan [1 ]
Kim, Michael [1 ]
Jauhar, Rajiv [1 ]
Meraj, Perwaiz [1 ]
机构：
[1] North Shore LIJ Hlth Syst, Hofstra North Shore LIJ Sch Med, Manhasset, NY USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2015年 / 65卷 / 10期
关键词：
D O I：
10.1016/S0735-1097(15)60115-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1139-094
引用
收藏
页码：A115 / A115
页数：1
相关论文
共 50 条
  • [31] Unfractionated heparin versus bivalirudin in patients undergoing primary percutaneous coronary intervention: a SWEDEHEART study
    Grimfjard, Per
    Erlinge, David
    Koul, Sasha
    Lagerqvist, Bo
    Svennblad, Bodil
    Varenhorst, Christoph
    James, Stefan K.
    EUROINTERVENTION, 2017, 12 (16) : 2009 - 2017
  • [32] Meta-Analysis of Effects of Bivalirudin Versus Heparin on Myocardial Ischemic and Bleeding Outcomes After Percutaneous Coronary Intervention
    Perez, Alberto E. Barria
    Rao, Sunil V.
    Jolly, Sanjit J.
    Pancholy, Samir B.
    Plourde, Guillaume
    Rimac, Goran
    Poirier, Yann
    Costerousse, Olivier
    Bertrand, Olivier F.
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 117 (08): : 1256 - 1266
  • [33] Bivalirudin versus Unfractionated Heparin during Percutaneous Coronary Intervention in Patients at High Risk for Bleeding
    Feldman, Alexander
    Suleiman, Khalid
    Bushari, Limor
    Yahalom, Malka
    Rozner, Ehud
    Freedberg, Nahum Adam
    Turgeman, Yoav
    INTERNATIONAL JOURNAL OF ANGIOLOGY, 2014, 23 (04) : 227 - 232
  • [34] Comparison of Safety and Efficacy of Unfractionated Heparin Versus Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention
    Rehmani, Ahmed
    Judkins, Chris
    Whelan, Alan
    Nguyen, Michael
    Schultz, Carl
    HEART LUNG AND CIRCULATION, 2017, 26 (12): : 1277 - 1281
  • [35] Impact of Bivalirudin Monotherapy on 30-day Outcomes in Patients with Acute Coronary Syndromes and Complex Coronary Stenoses Undergoing Percutaneous Coronary Intervention
    Goto, Kenji
    Lansky, Alexandra J.
    Cristea, Ecaterina
    Fahy, Martin
    Feit, Frederick
    Ohman, Magnus E.
    White, Harvey D.
    Alexander, Karen P.
    Bertrand, Michel E.
    Desmet, Walter
    Hamon, Martial
    Mehran, Roxana
    Stone, Gregg W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A66 - A66
  • [36] Bivalirudin versus heparin during percutaneous coronary intervention: a meta-analysis of randomized trials
    Cassese, Salvatore
    Byrne, Robert
    Schunkert, Heribert
    Berger, Peter B.
    Kastrati, Adnan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) : B135 - B135
  • [37] Benefit of Bivalirudin Versus Heparin After Transradial and Transfemoral Percutaneous Coronary Intervention
    MacHaalany, Jimmy
    Abdelaal, Eltigani
    Bataille, Yoann
    Plourde, Guillaume
    Duranleau-Gagnon, Pierre
    Larose, Eric
    Dery, Jean-Pierre
    Barbeau, Gerald
    Rinfret, Stephane
    Rodes-Cabau, Josep
    De Larochelliere, Robert
    Roy, Louis
    Costerousse, Olivier
    Bertrand, Olivier F.
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (12): : 1742 - 1748
  • [38] TRENDS IN UTILIZATION AND OUTCOMES OF BIVALIRUDIN VERSUS UNFRACTIONATED HEPARIN IN PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROME: A STATE-WIDE ANALYSIS (2012-2018)
    Mahmoud, Ahmed M.
    Kataruka, Akash
    Doll, Jacob Appel
    Jneid, Hani
    Hira, Ravi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 174 - 174
  • [39] Heparin versus bivalirudin for percutaneous coronary intervention: has the debate come to an end?
    Elgendy, Islam Y.
    Capodanno, Davide
    JOURNAL OF THORACIC DISEASE, 2017, 9 (11) : 4305 - 4307
  • [40] Percutaneous coronary intervention in patients with acute coronary syndrome: focus on bivalirudin
    Ramana, Ravi K.
    Lewis, Bruce E.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2008, 4 (03) : 493 - 505
12345